RecruitingNot ApplicableNCT06079021
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
Sponsor
University Hospital, Antwerp
Enrollment
20 participants
Start Date
Jun 8, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
A Prospective, Single-Center trial, in Patients With Acute on Chronic Liver Failure. Study of Standard Medical Care Plus CytoSorb® Compared to Standard Medical Care Alone in a historical group.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called CytoSorb for people with acute-on-chronic liver failure, anticoagulant adverse reaction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECytoSorb
Application of CytoSorb treatment for 72 hours in patients with ACLF
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06079021
Related Trials
Muscle Aging Phenotypes in Childhood Cancer Survivors
NCT07531498
Preoperative Sarcopenia and Postoperative Outcomes in Older Patients With Gastrointestinal Cancer
NCT07817758
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
NCT067225082 locations
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT065628031 location
C-Protein in Fatigue and Aging
NCT059262191 location